Physician profile
Ryan Patrick Morton
NPI 1922239268
$7,666.21
in general payments reported to CMS, 2019-2025
11 companies · $759 in 2025
The $759 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,126 · 2020: $46.05 · 2021: $2,761 · 2022: $293 · 2023: $792 · 2024: $1,890 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366 · Travel and Lodging: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,365.66 |
| Travel and Lodging | $1,075.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $2,496.33 | 2021-2023 | Gammatile |
| Medtronic, INC. | $2,102.47 | 2021-2025 | Pipeline, Axium Primetm, Rist |
| Penumbra, INC. | $1,613.65 | 2019-2025 | Penumbra System, Benchmark, Red 72 |
| Imperative Care, INC | $657.70 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom Rdl Radial Access System, 103cm |
| Stryker Corporation | $368.88 | 2021-2023 | Surpass Evolve |
| Balt USA, LLC | $205.22 | 2025 | Carrier Delivery Catheter |
| Microvention, INC. | $128.00 | 2019-2025 | Web Aneurysm Embolization System |
| Cardiva Medical, INC. | $41.53 | 2025 | Cardiva Vascade 6/7f Vcs |
| Depuy Synthes Sales INC. | $22.50 | 2020 | |
| Medtronic USA, INC. | $16.24 | 2020 | |
| Kls-Martin L.P. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.